Skip to main content
Caplight Logo









Laguna Bio

Laguna Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.lagunabio.com/

Last Round

Seed

Oct 1, 2022

Total Funding Raised

$11.95M

Company Overview

Laguna Bio is a biotechnology company developing next-generation attenuated microbial platforms to activate the innate immune system for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunotherapymicrobial vectorsolid tumor treatmentin vivo immunotherapycancer immunotherapyoncolytic therapygamma delta T cellsbiotechnologydrug discoveryprecision medicinenext-gen immunotherapybiopharmaclinical stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Laguna Bio Comparables

Compare Laguna Bio with similar companies based on industry and business-model similarity.

Laguna Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ernest Pharmaceuticals
79%
Neobe Therapeutics
78%
Prokarium
78%

Laguna Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2022
AcceleratorSep 1, 2022

Key People

Founding team and executive leadership

Russell Carrington

COO and co-founder

Founding Team

Jonathan Kotula

CEO and co-founder

Founding Team

Shannon Dahl

Strategic Advisor to CEO

Executive Team

Laguna Bio Investors

Notable investors and investment history

Laguna Bio investors
InvestorRounds
Pacific 8 VenturesSeed
IndieBioAccelerator
The Venture CollectiveSeed
SOSVSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors increased 48% MoM.

  • Nov 8, 2024

    Monthly visitors grew 35% MoM, reaching 1K.

Laguna Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Laguna Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Laguna Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range8
Year Founded2022
Last FundingOct 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?